Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Ending Cash Balance (2011 - 2026)

Updated

Grace Therapeutics (GRCE) reported Ending Cash Balance of $16.98 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 0.7% from $16.86 million a year earlier and up 23.4% from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Ending Cash Balance (2011 - 2026) Analysis & Trends

Dating back to fiscal Q1 2012, Grace Therapeutics' Ending Cash Balance record includes 59 quarters.

  • Ending Cash Balance has declined for five consecutive fiscal years, with a five-year compound annual growth rate of -19.7% (FY2021 to FY2026).
  • By fiscal year, Ending Cash Balance came in at $22.13 million in FY2025 (-3.8%), $23.01 million in FY2024 (-17.5%), $27.88 million in FY2023 (-8.1%) and $30.34 million in FY2022 (-40.4%).
  • Five-year quarterly Ending Cash Balance spans a low of $11.06 million in fiscal Q3 2025 and a high of $38.38 million in fiscal Q1 2023.
  • Year over year, Ending Cash Balance gained in four of the last eight quarters, with an average decline of 1.8%.
  • The high point for year-over-year Ending Cash Balance in five years was fiscal Q3 2026 (growth of 68.9%); the low point was fiscal Q2 2025 (a decline of 43.9%).
  • Per Business Quant data, the three fiscal quarters before Q2 2027 came in at $13.76 million (Q1 2027), $16.98 million (Q4 2026) and $18.67 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 16.91 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 10.77 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 9.65 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 7.94 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 6.44 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 1.88 Bn
10 Grace Therapeutics 35.10 Mn -35.61 Mn - 21.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 16.98 Mn
Jun 30, 2026 13.76 Mn
Mar 31, 2026 16.98 Mn
Dec 31, 2025 18.67 Mn
Sep 30, 2025 16.86 Mn
Jun 30, 2025 20.01 Mn
Mar 31, 2025 22.13 Mn
Dec 31, 2024 11.06 Mn
Sep 30, 2024 15.16 Mn
Jun 30, 2024 19.39 Mn
Mar 31, 2024 23.01 Mn
Dec 31, 2023 18.55 Mn
Sep 30, 2023 26.99 Mn
Jun 30, 2023 21.63 Mn
Mar 31, 2023 27.88 Mn
Dec 31, 2022 26.24 Mn
Sep 30, 2022 26.24 Mn
Jun 30, 2022 38.38 Mn
Mar 31, 2022 30.34 Mn
Dec 31, 2021 33.01 Mn
API Access

Grace Therapeutics Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=GRCE&period=max&api_key=YOUR_API_KEY